Browsing "1. Journal Papers" by Author : 1352

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 28 to 52 of 52

This table browses all dspace content
Issue DateTitleJournal Title
2009Impact of Grade, Hormone Receptor, and HER-2 Status in Women with Breast Cancer on Response to Specific Chemotherapeutic Agents by in vitro Adenosine Triphosphate-based Chemotherapy Response Assay. JOURNAL OF KOREAN MEDICAL SCIENCE
2021Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer NPJ BREAST CANCER
2016Intratumoral Agreement of High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopic Profiles in the Metabolic Characterization of Breast Cancer MEDICINE
2017Lack of both androgen receptor and forkhead box A1 (FOXA1) expression is a poor prognostic factor in estrogen receptor-positive breast cancer ONCOTARGET
2022Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade CANCER RESEARCH AND TREATMENT
2014Low-grade adenosquamous carcinoma of the breast with diverse expression patterns of myoepithelial cell markers on immunohistochemistry: a case study KOREAN JOURNAL OF PATHOLOGY
2016Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI PLOS ONE
2010Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic siteTUMORI J
2015Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics CELL RESEARCH
2011Molecular Subtypes and Tumor Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast CancerONCOLOGY
2012Overexpression of class III beta tubulin and amplified HER2 gene predict good response to paclitaxel and trastuzumab therapy PLOS ONE
2010Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistanceCANCER CHEMOTHERAPY AND PHARMACOLOGY
2012Primary Mucinous Cystadenocarcinoma of the Breast: Cytologic Finding and Expression of MUC5 Are Different from Mucinous Carcinoma KOREAN JOURNAL OF PATHOLOGY
2016Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers PLOS ONE
2012Rosai-Dorfman Disease in the breast with increased IgG4 expressing plasma cells: a case report KOREAN JOURNAL OF PATHOLOGY
2013S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial BMC CANCER
2011Subcutaneous phaeohyphomycosis caused by Phaeoacremonium species in a kidney transplant patient: the first case in Korea. KOREAN JOURNAL OF LABORATORY MEDICINE
2011The impact of a focally positive resection margin on the local control in patients treated with breast-conserving therapy.JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2011The impact of caveolin protein expression in tumor stroma on prognosis of breast cancerTUMOR BIOLOGY
2009The predictive role of E-cadherin and androgen receptor on in vitro chemosensitivity in triple-negative breast Cancer. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
2022Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer TECHNOLOGY IN CANCER RESEARCH & TREATMENT
2017부신 우연종으로 오인된 후복막 신경초종 1예 Korean Journal of Medicine
2015성장인자수용체-2 양성 유방암 조직에서 표적치료 전후의 성장인자수용체군 발현양상 Korean Journal of Clinical Oncology (대한임상종양학회지)
2009수질성유방암의 임상병리학적 특성과 예후 JOURNAL OF BREAST CANCER
2009아포크린 유방암의 임상병리적 특성 JOURNAL OF THE KOREAN SURGICAL SOCIETY
1

Browse

Links